Is a complete PCRX research report available?

No complete published report is available for Pacira BioSciences, Inc. (PCRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · USD

$36.4

-0.01 (-0.0%)· Recorded snapshot

Market cap	1.5B
Revenue (ttm)	746.2M
Net income (ttm)	14.6M
EPS (ttm)	$0.35
Shares out	39.9M
P/E (trailing)	103.4x
P/E (forward)	11.8x
Volume	695,180
Beta	0.25

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001396814
Company name	Pacira BioSciences, Inc.
Country	United States
Country code	US
CUSIP number	695127100
Earnings date	2026-11-09
Earnings time	amc
Employees	829
Employees change	39
Employees growth	4.94%
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2011-02-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US6951271005
Last 10-K release date	2026-02-26
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.5B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$36.39
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PCRX
U.S. state	California
Website	https://www.pacira.com

Metric

Value

Amount currency

USD

CIK code

0001396814

Company name

Pacira BioSciences, Inc.

Country

United States

Country code

CUSIP number

695127100

Earnings date

2026-11-09

Earnings time

amc

Employees

829

Employees change

Employees growth

4.94%

Enterprise value

$1.6B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2006

In index

RUSSELL2000

Industry

Drug Manufacturers - Specialty & Generic

IPO date

2011-02-03

Is primary listing

Yes

Is SPAC

ISIN number

US6951271005

Last 10-K release date

2026-02-26

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.5B

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$36.39

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

PCRX

U.S. state

California

Website

https://www.pacira.com

Metric	Value
Adjusted P/E ratio	13.99x
Average P/E ratio (3Y)	92.51x
Average P/E ratio (5Y)	87.78x
Earnings yield	0.97%
EV/Earnings	110.05x
EV/EBIT	49.07x
EV/EBITDA	12.99x
EV/FCF	8.97x
EV/Sales	2.16x
FCF / EV yield	11.14%
FCF yield	12.38%
Forward EV/Sales	2.12x
Forward P/E	11.78x
Forward P/S	1.91x
Graham number	11.55663
Graham upside	-68.22%
Industry forward P/E	13.86x
Industry P/E	173.47x
Lynch fair value	$1.76
Lynch upside	-95.16%
P/(FCF - SBC) ratio	11.74x
P/(OCF - SBC) ratio	11.01x
P/B ratio	2.16x
P/E ratio	103.44x
P/FCF ratio	8.08x
P/OCF ratio	7.73x
P/S ratio	1.94x
PEG ratio	1.18x
Price / tangible book value	3.95x
Price/EBITDA ratio	11.69x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

13.99x

Average P/E ratio (3Y)

92.51x

Average P/E ratio (5Y)

87.78x

Earnings yield

0.97%

EV/Earnings

110.05x

EV/EBIT

49.07x

EV/EBITDA

12.99x

EV/FCF

8.97x

EV/Sales

2.16x

FCF / EV yield

11.14%

FCF yield

12.38%

Forward EV/Sales

2.12x

Forward P/E

11.78x

Forward P/S

1.91x

Graham number

11.55663

Graham upside

-68.22%

Industry forward P/E

13.86x

Industry P/E

173.47x

Lynch fair value

$1.76

Lynch upside

-95.16%

P/(FCF - SBC) ratio

11.74x

P/(OCF - SBC) ratio

11.01x

P/B ratio

2.16x

P/E ratio

103.44x

P/FCF ratio

8.08x

P/OCF ratio

7.73x

P/S ratio

1.94x

PEG ratio

1.18x

Price / tangible book value

3.95x

Price/EBITDA ratio

11.69x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	4.4%
EBITDA margin	16.61%
Effective tax rate	17.06%
FCF margin	24.06%
Gross margin	79.21%
Operating margin	4.4%
Pretax margin	2.37%
Profit margin	1.96%
Profit per employee	$17,657
Profitable quarters	4
Profitable years	1
Revenue per employee	$900,077
ROA	1.48%
ROA (5Y)	2.89%
ROCE	2.93%
ROE	2.05%
ROE (5Y)	0.46%
ROIC	3.21%
ROIC (5Y)	5.75%
SBC / revenue	7.5%
Tax / revenue	0.4%

Metric

Value

EBIT margin

4.4%

EBITDA margin

16.61%

Effective tax rate

17.06%

FCF margin

24.06%

Gross margin

79.21%

Operating margin

4.4%

Pretax margin

2.37%

Profit margin

1.96%

Profit per employee

$17,657

Profitable quarters

Profitable years

Revenue per employee

$900,077

ROA

1.48%

ROA (5Y)

2.89%

ROCE

2.93%

ROE

2.05%

ROE (5Y)

0.46%

ROIC

3.21%

ROIC (5Y)

5.75%

SBC / revenue

7.5%

Tax / revenue

0.4%

Metric	Value
EPS growth (QoQ)	68.44%
EPS growth 5Y	-38.04%
EPS growth quarters	1
EPS growth years	1
FCF growth	53.34%
FCF growth (Q)	502.51%
FCF growth (QoQ)	144.49%
FCF growth 3Y	12.32%
FCF growth 5Y	16.72%
Gross profit growth	7.08%
Gross profit growth (Q)	5.71%
Gross profit growth 3Y	8.76%
Gross profit growth 5Y	9.75%
Net income growth (QoQ)	59.57%
Net income growth 5Y	-39.05%
Net income growth quarters	1
Net income growth years	1
OCF growth	39.5%
OCF growth (Q)	378.36%
OCF growth (QoQ)	123.75%
OCF growth 10Y	21.79%
OCF growth 3Y	8.4%
OCF growth 5Y	7.84%
Operating income growth	-52.03%
Operating income growth (Q)	29.87%
Operating income growth 3Y	-21.67%
Operating income growth 5Y	-20%
Revenue growth	5.71%
Revenue growth (Q)	6.24%
Revenue growth (QoQ)	8.47%
Revenue growth 10Y	10.84%
Revenue growth 3Y	3.69%
Revenue growth 5Y	8.2%
Revenue growth quarters	11
Revenue growth years	15

Metric

Value

EPS growth (QoQ)

68.44%

EPS growth 5Y

-38.04%

EPS growth quarters

EPS growth years

FCF growth

53.34%

FCF growth (Q)

502.51%

FCF growth (QoQ)

144.49%

FCF growth 3Y

12.32%

FCF growth 5Y

16.72%

Gross profit growth

7.08%

Gross profit growth (Q)

5.71%

Gross profit growth 3Y

8.76%

Gross profit growth 5Y

9.75%

Net income growth (QoQ)

59.57%

Net income growth 5Y

-39.05%

Net income growth quarters

Net income growth years

OCF growth

39.5%

OCF growth (Q)

378.36%

OCF growth (QoQ)

123.75%

OCF growth 10Y

21.79%

OCF growth 3Y

8.4%

OCF growth 5Y

7.84%

Operating income growth

-52.03%

Operating income growth (Q)

29.87%

Operating income growth 3Y

-21.67%

Operating income growth 5Y

-20%

Revenue growth

5.71%

Revenue growth (Q)

6.24%

Revenue growth (QoQ)

8.47%

Revenue growth 10Y

10.84%

Revenue growth 3Y

3.69%

Revenue growth 5Y

8.2%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-8.1M
Depreciation and amortization	$91.1M
EBIT	$32.8M
EBITDA	$124M
EPS	$0.35
FCF per share	$4.50
Financing cash flow	$-376.2M
Free cash flow	$179.5M
Free cash flow minus SBC	$123.5M
Gross profit	$591M
Income taxes	$3M
Investing cash flow	$94.1M
Net borrowing	$-220.2M
Net cash flow	$-94.6M
Net income	$14.6M
Operating cash flow minus SBC	$131.7M
Operating income	$32.8M
Revenue	$746.2M
Stock-based compensation	$56M

Metric

Value

Capital expenditures

$-8.1M

Depreciation and amortization

$91.1M

EBIT

$32.8M

EBITDA

$124M

EPS

$0.35

FCF per share

$4.50

Financing cash flow

$-376.2M

Free cash flow

$179.5M

Free cash flow minus SBC

$123.5M

Gross profit

$591M

Income taxes

$3M

Investing cash flow

$94.1M

Net borrowing

$-220.2M

Net cash flow

$-94.6M

Net income

$14.6M

Operating cash flow minus SBC

$131.7M

Operating income

$32.8M

Revenue

$746.2M

Stock-based compensation

$56M

Metric	Value
Altman Z-Score	2
Book value per share	$16.87
Debt / EBITDA	2.97
Debt / equity	0.61
Debt / FCF	2.3
Goodwill	$19.6M
Interest coverage	2.12
Long-term assets	$628.8M
Long-term liabilities	$450M
Net cash (debt)	$-161.1M
Net cash / market cap	-11.11%
Net debt / EBITDA	1.3
Net debt / equity	0.24
Net debt / FCF	0.9
Piotroski F-Score	8
Property, plant and equipment	$175.2M
Shareholders' equity	$672M
Tangible book value	$366.9M
Tangible book value per share	$9.21
Total assets	$1.2B
Total cash	$251M
Total debt	$412.1M
Total liabilities	$572M
WACC	5.08%

Metric

Value

Altman Z-Score

Book value per share

$16.87

Debt / EBITDA

2.97

Debt / equity

0.61

Debt / FCF

2.3

Goodwill

$19.6M

Interest coverage

2.12

Long-term assets

$628.8M

Long-term liabilities

$450M

Net cash (debt)

$-161.1M

Net cash / market cap

-11.11%

Net debt / EBITDA

1.3

Net debt / equity

0.24

Net debt / FCF

0.9

Piotroski F-Score

Property, plant and equipment

$175.2M

Shareholders' equity

$672M

Tangible book value

$366.9M

Tangible book value per share

$9.21

Total assets

$1.2B

Total cash

$251M

Total debt

$412.1M

Total liabilities

$572M

WACC

5.08%

Metric	Value
Asset turnover	0.54
Current assets	$615.2M
Current liabilities	$122M
Current ratio	5.04
Inventory turnover	1.1
Net working capital	$252.5M
Quick ratio	3.21
Working capital	$493.2M
Working capital turnover	1.61

Metric

Value

Asset turnover

0.54

Current assets

$615.2M

Current liabilities

$122M

Current ratio

5.04

Inventory turnover

1.1

Net working capital

$252.5M

Quick ratio

3.21

Working capital

$493.2M

Working capital turnover

1.61

Metric	Value
Buyback yield / dilution	7.82%
Dividend yield	0%
Shareholder yield	7.82%

Metric

Value

Buyback yield / dilution

7.82%

Dividend yield

Shareholder yield

7.82%

Metric	Value
10Y price change	5.79%
10Y return CAGR	0.56%
10Y total return	5.79%
150-day SMA	$25.66
15Y price change	249.57%
15Y return CAGR	8.7%
15Y total return	249.57%
1D price change	-0.04%
1M price change	44.87%
1M total return	44.87%
1W price change	0.03%
1W total return	0.03%
1Y price change	70.61%
1Y return CAGR	70.67%
1Y total return	70.61%
20-day SMA	$33.53
200-day SMA	$24.70
3M price change	37.48%
3M total return	37.48%
3Y price change	31.99%
3Y return CAGR	9.69%
3Y total return	31.99%
50-day SMA	$28.57
50-day SMA vs 200-day SMA	50over200
52-week high	$36.67
52-week high date	2026-10-15
52-week low	$18.80
52-week low date	2026-01-20
5Y price change	-29.56%
5Y return CAGR	-6.77%
5Y total return	-29.56%
6M price change	42.43%
6M total return	42.43%
All-time high	$121.95
All-time high date	2015-02-25
All-time low	$6.16
All-time low date	2011-02-16
Average true range (ATR)	$0.62
Average volume	2.6M
Beta (1Y)	0.12
Beta (2Y)	0.65
Beta (5Y)	0.25
Change from 52-week high	-0.76%
Change from 52-week low	93.54%
Change from all-time high	-70.16%
Change from all-time low	490.75%
Change from open	0.01%
Day's gap	-0.05%
Dollar volume	$25.3M
High price	$36.40
Low price	$36.36
Monthly RSI	62.79
Open price	$36.38
Position in 52-week range	62.5%
Premarket change	0.03%
Premarket close	$36.40
Premarket price	$36.41
Premarket volume	3.9K
Previous close	$36.40
Price vs 150-day SMA	41.81%
Price vs 20-day SMA	8.52%
Price vs 200-day SMA	47.35%
Price vs 50-day SMA	27.36%
Relative volume	0.26
RSI	83.22
Sharpe ratio	1.12
Sharpe ratio (3Y)	0.39
Sharpe ratio (5Y)	0.03
Sortino ratio	2.49
Sortino ratio (3Y)	0.65
Sortino ratio (5Y)	0.15
Volume	695.2K
Weekly RSI	77.3
YTD price change	40.61%
YTD total return	40.61%

Metric

Value

10Y price change

5.79%

10Y return CAGR

0.56%

10Y total return

5.79%

150-day SMA

$25.66

15Y price change

249.57%

15Y return CAGR

8.7%

15Y total return

249.57%

1D price change

-0.04%

1M price change

44.87%

1M total return

44.87%

1W price change

0.03%

1W total return

0.03%

1Y price change

70.61%

1Y return CAGR

70.67%

1Y total return

70.61%

20-day SMA

$33.53

200-day SMA

$24.70

3M price change

37.48%

3M total return

37.48%

3Y price change

31.99%

3Y return CAGR

9.69%

3Y total return

31.99%

50-day SMA

$28.57

50-day SMA vs 200-day SMA

50over200

52-week high

$36.67

52-week high date

2026-10-15

52-week low

$18.80

52-week low date

2026-01-20

5Y price change

-29.56%

5Y return CAGR

-6.77%

5Y total return

-29.56%

6M price change

42.43%

6M total return

42.43%

All-time high

$121.95

All-time high date

2015-02-25

All-time low

$6.16

All-time low date

2011-02-16

Average true range (ATR)

$0.62

Average volume

2.6M

Beta (1Y)

0.12

Beta (2Y)

0.65

Beta (5Y)

0.25

Change from 52-week high

-0.76%

Change from 52-week low

93.54%

Change from all-time high

-70.16%

Change from all-time low

490.75%

Change from open

0.01%

Day's gap

-0.05%

Dollar volume

$25.3M

High price

$36.40

Low price

$36.36

Monthly RSI

62.79

Open price

$36.38

Position in 52-week range

62.5%

Premarket change

0.03%

Premarket close

$36.40

Premarket price

$36.41

Premarket volume

3.9K

Previous close

$36.40

Price vs 150-day SMA

41.81%

Price vs 20-day SMA

8.52%

Price vs 200-day SMA

47.35%

Price vs 50-day SMA

27.36%

Relative volume

0.26

RSI

83.22

Sharpe ratio

1.12

Sharpe ratio (3Y)

0.39

Sharpe ratio (5Y)

0.03

Sortino ratio

2.49

Sortino ratio (3Y)

0.65

Sortino ratio (5Y)

0.15

Volume

695.2K

Weekly RSI

77.3

YTD price change

40.61%

YTD total return

40.61%

Metric	Value
Float	39.1M
Float percentage	98.16%
Shares change (QoQ)	-1.49%
Shares change (YoY)	-7.82%
Shares held by insiders	1.81%
Shares held by institutions	106.44%
Shares outstanding	39.9M
Short % of float	20.64%
Short % of shares	20.26%
Short ratio	14.5 days

Metric

Value

Float

39.1M

Float percentage

98.16%

Shares change (QoQ)

-1.49%

Shares change (YoY)

-7.82%

Shares held by insiders

1.81%

Shares held by institutions

106.44%

Shares outstanding

39.9M

Short % of float

20.64%

Short % of shares

20.26%

Short ratio

14.5 days

Pacira BioSciences, Inc. (PCRX)

Price

Financial snapshot

Fair-value bridge

Latest news · PCRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PCRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PCRX

Frequently asked questions